Category: Abbott

Busting Myths of Glucose Sensing Technology and Rethinking the Treatment Limits

Abbott |
Tuesday

Chair: Stephen Dixon (UK) 18:30 – 18:35 Welcome and introduction Stephen Dixon (UK) 18:35 – 18:50 Myth #1: Glucose sensing technology is too complex for

Moving Beyond HbA1c: New Standards and Target Destinations for Optimizing Glycemic Control with CGM

Abbott Diabetes Care |
Monday

Chair: Emma Wilmot (UK) 14:30 – 14:45 The Foundational Importance of Sensor-Based CGM in the Diabetes Specialist Setting: Identifying New Glycemic Metric “Destinations” Beyond HbA1c Emma

Rethinking Treatment Limits: Can Older People Handle Glucose Sensing Technology?

Abbott |
Wednesday

Chair: Stephen Dixon (UK) 12:15 – 12:20 Welcome and introduction Stephen Dixon (UK) 12:20 – 12:40 Adoption and Efficacy of Glucose Sensing Technology in Older

Category: Abbott

Busting Myths of Glucose Sensing Technology and Rethinking the Treatment Limits Abbott | Tuesday

Moving Beyond HbA1c: New Standards and Target Destinations for Optimizing Glycemic Control with CGM Abbott Diabetes Care | Monday

Rethinking Treatment Limits: Can Older People Handle Glucose Sensing Technology? Abbott | Wednesday

Busting Myths of Glucose Sensing Technology and Rethinking the Treatment Limits

Abbott |
Tuesday

Moving Beyond HbA1c: New Standards and Target Destinations for Optimizing Glycemic Control with CGM

Abbott Diabetes Care |
Monday

Rethinking Treatment Limits: Can Older People Handle Glucose Sensing Technology?

Abbott |
Wednesday